Evidence map›Paper›PMID 23300556›Full record

ArticlePloS one2012

Efficient measurement of opsonising antibodies to Plasmodium falciparum merozoites.

Danika L Hill, Emily M Eriksson, Amandine B Carmagnac, Danny W Wilson, Alan F Cowman, Diana S Hansen, Louis Schofield

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 32 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Molecular Characterization and Immuno-Reactivity Patterns of a NovelFrontiers in cellular and infection microbiology · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Danika L HillWalter and Eliza Hall Institute for Medical Research, Parkville, Victoria, Australia.
Emily M Eriksson
Amandine B Carmagnac
Danny W Wilson
Alan F Cowman
Diana S Hansen
Louis Schofield
Walter and Eliza Hall Institute of Medical Research · AUUniversity of Melbourne · AU

Funding

TransmissionU19AI089686 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI KAZURA, JAMES WALTER · 2010 to 2016
$9.9M
NIAID NIH HHS AI089686NIAID NIH HHS U19 AI089686
6 · The paper itself

Abstract

backgroundAntibodies targeting merozoites are important in protection from malaria. Therefore, merozoite surface proteins are attractive vaccine candidates. There is a need for robust functional assays to investigate mechanisms of acquired immunity and vaccine efficacy. To date, the study of merozoite phagocytosis has been confounded by the complexity and variability of in vitro assays. METHODOLOGY/PRINCIPAL

findingsWe have developed a new flow cytometry-based merozoite phagocytosis assay. An optimized merozoite preparation technique produced high yields of merozoites separated from haemozoin. Phagocytosis by the undifferentiated THP-1 monocytic cell line was mediated only by Fc Receptors, and was therefore ideal for studying opsonising antibody responses. The assay showed robust phagocytosis with highly diluted immune sera and strong inter-assay correlation. The assay effectively measured differences in opsonisation-dependent phagocytosis among individuals. CONCLUSIONS/SIGNIFICANCE: This highly reproducible assay has potential applications in assessing the role of opsonic phagocytosis in naturally acquired immunity and vaccine trials.

Indexed as

AdolescentAdultAntibodies, ProtozoanAntigens, ProtozoanCells, CulturedChildChild, PreschoolFlow CytometryFluorescent Antibody Technique, IndirectHumansImmunoblottingMalaria, FalciparumMerozoitesMiddle AgedMonocytesOpsonin ProteinsAntibodies, ProtozoanAntigens, ProtozoanOpsonin ProteinsReceptors, Fc

Identifiers

PMID23300556
PMCPMC3530572
OpenAlexW2086580403

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.